The puppeteer pulls the strings!?
Have a heavy lid on all the dirty "secrets"(!?).
That's how the Loot Maar Raj functions.
Never mind if these are really no secrets.
(Just don't miss: <
https://www.businessinsider.in/india/news/aidan-asks-dcgi-to-withdraw-approval-for-bharat-biotechs-covaxin/articleshow/80078041.cms>.)

No Data Available (NDA)!

Just the other day - only last Sunday, someone had clarified (or assured?)
that Covaxin is only a *back-up*.
<<All India Institute of Medical Sciences (AIIMS) director Dr Randeep
Guleria on Sunday said that the Covid-19 vaccine manufactured by Bharat
Biotech will be used as a back-up for now.>>
(Ref.: <
https://www.livemint.com/news/india/bharat-biotech-covid-vaccine-can-be-for-back-up-when-cases-surge-aiims-director-11609668694582.html
>.)

Now, in a jiffy, both are just on par.
Now, *both* would "ensure smooth rollout of (their respective) vaccine(s)."
Wow!!!
Human lives have just no value!
Of course, all in the name of saving lives!

<<This statement comes after a public spat between Bharat Biotech’s Dr Ella
and Serum Institute’s Adar Poonawalla.

Poonawalla had told NDTV that only Pfizer, Moderna and Oxford-AstraZeneca
had proven efficacy, saying that other vaccine candidates, including Bharat
Biotech’s Covaxin, were “safe, just like water.”

In response to this, an indignant Ella had retorted “We do 200 percent
honest clinical trials and yet we receive backlash. If I am wrong, tell me.
Some companies have branded me like 'water'. I want to deny that. We are
scientists.">>

(Ref.: <
https://www.thequint.com/news/india/serum-institute-bharat-biotech-joint-statement-on-coronavirus-vaccine-covid-19
>.)

Sukla

-- 
You received this message because you are subscribed to the Google Groups 
"Green Youth Movement" group.
To unsubscribe from this group and stop receiving emails from it, send an email 
to [email protected].
To view this discussion on the web, visit 
https://groups.google.com/d/msgid/greenyouth/CACEsOZh5VZYUoksKuB4sXfJVmM4XEa63fkDH-fkgdkhEZK4GHQ%40mail.gmail.com.

Reply via email to